Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines has informed BSE that its trading window will be closed starting 1st October 2025, in line with SEBI's insider trading rules. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ended 30th September 2025 (Q2 FY26). The exact date of the board meeting to approve these results has not been announced yet and will be communicated later. During this period, all designated persons — including promoters, directors, auditors, key managerial personnel, and their immediate relatives — are prohibited from buying, selling, or pledging the company's shares.
No direct impact on shareholders; this is a routine compliance step before the upcoming quarterly results announcement. Investors should watch for the board meeting date, as the results declaration could be a near-term catalyst for the stock.